celecoxib has been researched along with aldosterone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harding, P | 1 |
Bauer, C; Dorn, M; Godes, M; Herzfeld, S; Hocher, B; Kurtz, A; Maser-Gluth, C; Neumayer, HH; Priem, F; Richter, CM; Schneider, W; Slowinski, T; Wagner, C | 1 |
Frölich, JC; Gutzki, FM; Marhauer, V; Stichtenoth, DO; Tsikas, D | 1 |
Aw, TJ; Billah, B; Krum, H; Liew, D; Morel-Kopp, MC; Schneider, HG; Tofler, GH | 1 |
Adrahtas, A; Bertucci, MC; Cheung, RY; Krum, H; Ma, JY; Wang, BH | 1 |
Edwards, DG; Farquhar, WB; Gardner, TJ; Ray, CA; Rose, WC; Stillabower, M; Wenner, MM | 1 |
Bullins, KW; Campbell, GE; Conder, CM; Cooper, DL; Denham, JW; Hanley, AV; Harirforoosh, S; Lynch, SP; Murrell, DE; Palau, VE; Panus, PC; Singh, K | 1 |
3 trial(s) available for celecoxib and aldosterone
Article | Year |
---|---|
Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Body Weight; Celecoxib; Creatinine; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Diuretics; Female; Furosemide; Humans; Indomethacin; Kidney; Potassium; Prostaglandins; Pyrazoles; Renin; Sodium; Sulfonamides; Thromboxane B2 | 2005 |
Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?
Topics: Aged; Aldosterone; Blood Pressure; Celecoxib; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Female; Humans; Hypertension; Lactones; Middle Aged; Osteoarthritis; Prospective Studies; Pyrazoles; Sulfonamides; Sulfones | 2006 |
Celecoxib does not alter cardiovascular and renal function during dietary salt loading.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Cardiac Output; Cardiovascular System; Celecoxib; Cyclooxygenase 2 Inhibitors; Humans; Kidney; Kidney Function Tests; Placebos; Prostaglandins; Pyrazoles; Renin; Sodium; Sodium Chloride, Dietary; Sulfonamides | 2011 |
4 other study(ies) available for celecoxib and aldosterone
Article | Year |
---|---|
Do COX-2 inhibitors reduce renal fibrosis?
Topics: Aldosterone; Animals; Blood Pressure; Celecoxib; Creatinine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Glomerular Filtration Rate; Humans; Hypertension, Renovascular; Isoenzymes; Kidney; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Renin; Sulfonamides; Systole; Urea | 2004 |
Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.
Topics: Aldosterone; Animals; Biomarkers; Blood Pressure; Celecoxib; Creatinine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Glomerular Filtration Rate; Hypertension, Renovascular; Isoenzymes; Kidney; Male; Models, Animal; Models, Cardiovascular; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred WKY; Renin; Sulfonamides; Systole; Time Factors; Urea | 2004 |
Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Celecoxib; Collagen; Cyclooxygenase 2 Inhibitors; Female; Fibroblasts; Fibrosis; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactones; Male; Myocardium; Myocytes, Cardiac; Naproxen; Pyrazoles; Rats; Renin-Angiotensin System; Sulfonamides; Sulfones; Vasoconstrictor Agents | 2010 |
Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.
Topics: Administration, Oral; Aldosterone; Analysis of Variance; Animals; Blood Pressure; Blood Urea Nitrogen; Celecoxib; Electrolytes; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Kidney Diseases; Misoprostol; Potassium; Pyrazoles; Rats; Sodium; Sulfonamides; Troponin I | 2014 |